This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure, featuring both difluoroacetic and acetamido groups, makes it valuable in the development of compounds with potential therapeutic effects. It is often employed in the creation of molecules targeting specific enzymes or receptors, particularly in the fields of oncology and anti-inflammatory treatments. Additionally, its fluorine-containing groups enhance the metabolic stability and bioavailability of the resulting drugs, making it a critical component in modern drug design and development processes.